Literature DB >> 851303

Osmolality changes during hemodialysis. Natural history, clinical correlations, and influence of dialysate glucose and intravenous mannitol.

F Rodrigo, J Shideman, R McHugh, T Buselmeier, C Kjellstrand.   

Abstract

We studied the influence of both a high-glucose-concentration dialysate (717 mg/dl) and intravenous mannitol (1g/kg) on the serum osmolality changes in stable patients on chronic dialysis. During regular dialysis, serum osmolality fell 10 mosmol/kg H2O. This fall was reduced to 5.2 mosmol/kg H2O when the high-glucose-concentration dialysate was used, and to 4.3 mosmol/kg H2O when intravenous mannitol was used. When the two methods were combined, the serum osmolality fall was reduced to 1.7 mosmol/kg H2O. The clinical signs of disequilibrium declined (from 67% to 10%) in parallel with the decline in serum osmolality changes. This fall was independent of the ultrafiltration rate. A high-glucose-concentration dialysate and intravenous mannitol can each reduce the osmolality changes that occur during hemodialysis, but when used alone, intravenous mannitol is more effective of the two. The reduction of osmolality changes also leads to reduction of the mild clinical signs usually associated with disequilibrium.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851303     DOI: 10.7326/0003-4819-86-5-554

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  23 in total

1.  Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging.

Authors:  J P Galons; T Trouard; A F Gmitro; Y H Lien
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Optimal dialysate sodium-what is the evidence?

Authors:  Finnian R Mc Causland; Sushrut S Waikar
Journal:  Semin Dial       Date:  2014-01-23       Impact factor: 3.455

3.  More on the dialysis disequilibrium syndrome.

Authors:  A I Arieff
Journal:  West J Med       Date:  1989-07

4.  Dialysis disequilibrium syndrome.

Authors:  C P Harris; J J Townsend
Journal:  West J Med       Date:  1989-07

Review 5.  Osmolality and blood pressure stability during hemodialysis.

Authors:  Anika T Singh; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-07-09       Impact factor: 3.455

Review 6.  Osmotherapy for elevated intracranial pressure: a critical reappraisal.

Authors:  R Nau
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 7.  Kidney-brain crosstalk in the acute and chronic setting.

Authors:  Renhua Lu; Matthew C Kiernan; Anne Murray; Mitchell H Rosner; Claudio Ronco
Journal:  Nat Rev Nephrol       Date:  2015-08-18       Impact factor: 28.314

8.  Dialysis dose and intradialytic hypotension: results from the HEMO study.

Authors:  Finnian R Mc Causland; Steven M Brunelli; Sushrut S Waikar
Journal:  Am J Nephrol       Date:  2013-10-26       Impact factor: 3.754

Review 9.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

Review 10.  Mannitol.

Authors:  A R Nissenson; R E Weston; C R Kleeman
Journal:  West J Med       Date:  1979-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.